Shareholders meeting

Date: 28.09.2026 To, To, BSE Limited National Stock Exchange of India Listing Department Limited Phiroze Jeejeebhoy Towers, Listing Department “Exchange Plaza,” 25th Floor, Dalal Street, C-1, Block G, Bandra – Kurla Complex, Mumbai - 400 001 Bandra (E), Mumbai - 400 051 Scrip Code: 544666 Scrip Code: GKSL Dear Sir/Madam Sub: Proceedings of the 7th Annual General Meeting (“AGM”) Ref: Regulation 30 read with Para A (13) of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) The 7th AGM of the Company was held on Monday, September 28, 2026 at the Registered office of the Company. Proceeding: 1) Quorum was present 2) Mr Pragnesh Bharpoda, Chairman and Managing Director, Mrs Bharti Pragnesh Bharpoda, Wholetime Director, Mrs Anita Bharpoda, Non Executive Non Independent Director, Mr Jagdish Thakkar, Independent Director and Chairman of Audit Committee, Mr Udayan Kachchi, Independent Director and Chairman of Stakeholders Relationship Committee, Dr Kairavi Shah, Independent Director and Chairman of Nomination and Remuneration Committee were present 3) Key Managerial Personnel- Mrs Bhavika Patel, Chief Financial Officer, Mrs Vishakha Phadke, Company Secretary & Compliance Officer were present 4) Representatives from Statutory Auditors, Secretarial Auditor and Scrutinizer were present 5) Mr Pragnesh Bharpoda, Chairman, delivered speech. 6) The resolutions for the items mentioned in the AGM notice dated August 24, 2026 were passed through poll and remote evoting. The gist of the items is as under: i. Adoption of Audited Financial Statements [Standalone and Consolidated] of the Company for the financial year ended March 31, 2026, together with the reports of the Board of Directors and Auditors thereon. ii. Appointment of a Director retiring by rotation. iii. Appointment of Secretarial Auditors iv. Appointment of Mr Paresh Dhoti as an Independent Director v. Appointment of Mrs Disha Bharpoda as Independent Director vi. Approval of Revision in Remuneration of Managing Director vii. Approval of Revision in Remuneration of Wholetime Director viii. Approval under Section 180(1)(c) of the Companies Act, 2013 ix. Approval under Section 180(1)(a) of the Companies Act, 2013 x. Approve increase in threshold of loans/ guarantees, providing of securities and making of investments in securities under section 186 of the Companies Act, 2013 xi. Approval to advance any loan/give guarantee/provide security under section 185 of the Companies Act, 2013 xii. Approve related party transactions The Members were informed that for those who have not cast their vote through remote evoting can cast their votes through ballot paper at the Meeting. Chairman informed the members that the Annual Report for the FY 2025-26 along with the Notice of the 7th AGM is already sent by Electronic Mode to all the Members and the same is also available on Company’s website as well as on BSE and NSE website. With the consent of the Members, the Notice convening the 7th AGM and the Auditors Report were taken as read. Kindly acknowledge the receipt of the above. Voting results of the AGM are being filed separately. Thank you Yours faithfully For Gujarat Kidney And Superspeciality Limited Vishakha Phadke Company Secretary & Compliance Officer